[Retracted] The Investigation on Nosocomial Infection of Acinetobacter baumannii and the Clinical Analysis of Sequential Therapy of Cefoperazone/Sulbactam Sodium for Intracranial Infection

Table 1

Univariate analysis results.

Normal information	Infection group ()	Control group ()
Age (years)	66.4 ± 7.1	63.1 ± 6.8	2.705	0.008
BMI (kg/m^2)	23.41 ± 1.55	23.28 ± 1.67	0.451	0.653
Operation time (min)	174.2 ± 22.5	170.7 ± 23.2	0.862	0.390
Gender (%)			0.508	0.476
Male	29 (60.42)	52 (54.17)
Female	19 (39.58)	44 (45.83)
Concomitant disease (%)
Hypertension	23 (47.92)	35 (36.46)	1.747	0.186
Diabetes	16 (33.33)	23 (23.96)	1.424	0.233
Coronary heart disease	6 (12.5)	8 (8.33)	0.633	0.426
Chronic obstructive pulmonary disease	15 (31.25)	14 (14.58)	5.527	0.019
Type of neurological disease (%)
Hypertensive intracerebral hemorrhage	11 (22.92)	34 (35.42)	2.327	0.127
Cerebral infarction	14 (29.17)	40 (41.67)	2.133	0.144
Intracranial tumor	12 (25)	7 (7.29)	8.761	0.003
Traumatic brain injury	8 (16.67)	5 (5.21)	5.116	0.024
Other	3 (6.25)	8 (8.33)	0.699	0.403
Prophylactic use of antibiotics (%)			5.116	0.024
Yes	40 (83.33)	91 (94.79)
No	8 (16.67)	5 (5.21)
Postoperative blood transfusion (%)			0.924	0.336
Yes	22 (45.83)	36 (37.5)
No	26 (54.17)	60 (62.5)
Postoperative drainage time (%)			12.382	0.000
≥3 d	25 (52.08)	22 (22.92)
<3 d	23 (47.92)	74 (77.08)
Postoperative hospital stay (%)			8.533	0.003
≥10 d	38 (79.17)	52 (54.17)
<10 d	10 (20.83)	44 (45.83)